Olema Pharmaceuticals, Inc. (OLMA)
21.55
-1.01
(-4.48%)
USD |
NASDAQ |
Mar 06, 16:00
21.54
-0.01
(-0.05%)
After-Hours: 20:00
Olema Pharmaceuticals Cash from Investing (Quarterly) : 17.27M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -322.77M |
| Corvus Pharmaceuticals, Inc. | -2.618M |
| Protagonist Therapeutics, Inc. | 48.82M |
| BridgeBio Pharma, Inc. | -13.75M |
| Oric Pharmaceuticals, Inc. | 16.98M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.53M |
| Cash from Financing (Quarterly) | 0.041M |
| Free Cash Flow | -134.67M |
| Free Cash Flow Per Share (Quarterly) | -0.4027 |
| Free Cash Flow to Equity (Quarterly) | -34.25M |
| Free Cash Flow to Firm (Quarterly) | -34.53M |
| Free Cash Flow Yield | -7.55% |